1 insider bought €11k of shares over the last 90 days, the latest filed 24 Jul 2026.
This page follows insider dealings at Shanghai Bio-heart Biological Technology Co., Ltd. - B -H Sh as filed with HKEX. From 18 October 2025 to 18 October 2026, the disclosure feed for Shanghai Bio-heart Biological Technology Co., Ltd. - B -H Sh logged 45 filings by 1 insider.
The flow runs one way only: 1 insider bought (45 purchases totalling €1.1M) and nobody sold on the market. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 1 senior executive. Wang Philip Li filed the largest purchase, €361k, on 18 May 2026.
Compared with its exchange (750 companies, median 5 filings), a count of 45 filings is above the norm. Looking back to 2026, when coverage begins, insiders filed 45 purchases and no sales.
The most recent open-market purchase was published on 24 July 2026, 86 days ago. Half of the filings or more reach the HKEX feed on the day of the trade. Until a filing is published, the market cannot know about the trade.
Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 45 declarations
Shanghai Bio-heart Biological Technology Co., Ltd. is a company focused on the development of biological technologies. It specializes in the research and production of innovative biological products.